Startups & Business News

Bitfount Secures €6.8 Million to Transform Clinical Research with Federated AI

futureTEKnow
July 25, 2025

Smashing Data Silos in Healthcare

London-based startup Bitfount has captured attention with a €6.8 million Series A funding round aimed at breaking down the notorious data silos in clinical research. In an industry often hampered by fragmented health data and privacy regulations, Bitfount’s approach stands out: their federated AI network enables healthcare organizations to collaborate securely while keeping sensitive data local and private.

What Makes Bitfount’s Solution Different?

Conventional clinical research has long been slowed by the challenge of integrating data from multiple hospitals and labs, each reluctant or legally unable to share raw patient information. Bitfount solves this by dispatching AI algorithms directly to the data’s location, rather than shuffling data between institutions. This technique, called federated learning, preserves privacy while unlocking cross-institutional insights that previously remained out of reach.

Key Benefits and Real-World Impact

Enhanced collaboration: Hospitals and pharmaceutical companies can analyze electronic health records (EHRs) and medical imaging data together, without exchanging raw data.
Accelerated clinical trials: In a pilot with Moorfields Eye Hospital, Bitfount’s platform slashed screening failures from 60% to just 14%, identifying over 600 eligible patients from a single site using both EHR and imaging analysis.
Maintained patient privacy: Data remains on local infrastructure, meeting rigid privacy standards while allowing broad analytics.

The Founders Behind the Innovation

Bitfount was created in 2020 by Dr. Blaise Thomson and Dr. Naaman Tammuz. Dr. Thomson previously co-founded VocalIQ (later acquired by Apple), contributed as Chief Architect for Siri Understanding, and led Apple’s Cambridge office. Their mission centers on unlocking the value of sensitive healthcare data to advance medical AI safely and responsibly.

Funding Momentum and Future Roadmap

The €6.8 million investment was led by Parkwalk Advisors, joined by Ahren Innovation Capital, Pace Ventures, Foresight Group, and Portfolio Ventures. Bitfount will channel the funds into:

Global expansion of its federated AI platform.
Deepening partnerships with pharma companies and research groups.
Broadening the platform’s capabilities from trial design to regulatory approval.

As the UK steers toward becoming a global leader in life sciences, Bitfount’s privacy-first, AI-powered infrastructure could greatly accelerate the pace and diversity of medical breakthroughs.

Why This Matters for the Future of Research

Bitfount’s platform is at the forefront of a new era in digital health, offering a blueprint for secure, scalable innovation in clinical trials. By letting AI go to the data rather than trying to centralize everything, Bitfount combines speed, compliance, and collaboration—without ever compromising on privacy. This marks a major leap forward for both patients and researchers, charting a course toward quicker, safer advancements in healthcare.

futureTEKnow is a leading source for Technology, Startups, and Business News, spotlighting the most innovative companies and breakthrough trends in emerging tech sectors like Artificial Intelligence (AI), Robotics, and the Space Industry.

Become a contributor

Find out how

Discover the companies and startups shaping tomorrow — explore the future of technology today.